The influence of growth hormone on tumour necrosis factor and neutrophil leukocyte function in sepsis

Scandinavian Journal of Infectious Diseases

Volumn 29, Issue 4, 1997, Pages 393-399

  Balteskard, Lise ^a,c   Unneberg, Kjetil ^a   Halvorsen, Dag ^a   Ytrebø, Lars M ^b   Waage, Anders ^b   Sjursen, Haakon ^a   Revhaug, Arthur ^a  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; GROWTH HORMONE; HUMAN GROWTH HORMONE; OXYGEN RADICAL; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOASSAY; CELL FUNCTION; CONTROLLED STUDY; ESCHERICHIA COLI; FLOW CYTOMETRY; GRAM NEGATIVE BACTERIUM; IMMUNE SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; METABOLITE; NEUTROPHIL; NONHUMAN; OXIDATION; PHAGOCYTOSIS; PROVOCATION TEST; RESPIRATORY BURST; SEPSIS; SWINE;

EID: 0030656582     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549709011837     Document Type: Article

References (57)

1. Rom WN, Basset P, Fells GA, Nukiwa T, Trapnell BC, Crysal RO. Alveolar macrophages release an insulin-like growth factor I-type molecule. J Clin Invest 82: 1685-93, 1988.
2. Solomkin JS, Jenkins MK, Nelson RD, Chenoweth D, Simmons RL. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation. Surgery 90: 319-27, 1981.
3. Lanser ME, Mao P, Brown G, Coleman B, Siegel JH. Serum-mediated depression of neutrophil chemiluminescence following blunt trauma. Ann Surg 202: 111-8, 1985.
4. Vespasiano MC, Lewandoski JR, Zimmerman JJ. Longitudinal analysis of neutrophil superoxide union generation in patients with septic shock. Crit Care Med 21: 666-72, 1993.
5. Røkke O, Revhaug A, Giercksky KE. Polymorphonuclear leucocyte activation after trauma: evidence for increased generation of oxygen free radicals in response to in vitro endotoxin stimulation. Acta Chir Scand 155: 233-9, 1989.
6. Waage A, Halstensen A, Espevik T. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1: 355-7, 1987.
7. Damas P, Reuter A, Gysen P, Demonty J, Lamy M, Franchimont P. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 17: 975-8, 1989.
8. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330: 662-4, 1987.
9. Silva AT, Bayston KF. Cohen J. Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-alpha in experimental gram-negative shock. J Infect Dis 162: 421-7, 1990.
10. Zamir O, Hasselgren PO, Kunkel SL, Frederick J, Higashiguchi T, Fischer JE. Evidence that tumor necrosis factor participates in the regulation of muscle proteolysis during sepsis. Arch Surg 127: 170-4, 1992.
11. Schmidt H, Rush B, Simonian G, Murphy T, Hsieh J, Condon M. Thalidomide inhibits TNF response and increases survival following endotoxin injection in rats. J Surg Res 63: 143-6, 1996.
12. Neuner P, Klosner G, Schauer E, Pourmojib M, Macheiner W, Grunwald C, et al. Pentoxifylline in vivo down-regulates the release of IL-1 beta, IL-6, IL-8 and tumour necrosis factor-alpha by human peripheral blood mononuclear cells. Immunology 83: 262-7, 1994.
13. Wilmore DW, Moylan JAJ, Bristow BF, Mason ADJ, Pruitt BAJ. Anabolic effects of human growth hormone and high caloric feedings following thermal injury. Surg Gynecol Obstet 138: 875-84, 1974.
14. Voerman BJ, Strack-van-Schijndel RJ, de-Boer H, Groeneveld AB, Nauta JP, van-der-Veen EA, Thijs LG. Effects of human growth hormone on fuel utilization and mineral balance in critically ill patients on full intravenous nutritional support. J Crit Care 9: 143-50, 1994.
15. Mjaaland M, Unneberg K, Hotvedt R, Revhaug A. Nitrogen retention induced by growth hormone after gastrointestinal surgery in patients with epidural analgesia and total parenteral nutrition. Eur J Surg 157: 21-7, 1991.
16. Gore DC, Honeycutt D, Jahoor F, Wolfe RR, Herndon DN Effect of exogenous growth hormone on whole-body and isolated- limb protein kinetics in burned patients. Arch Surg 126: 38-43, 1991.
17. Nolten WE, Goldstein D, Lindstrom M, McKenna MV, Carlson IH, Trump DL, et al. Effects of cytokines on the pituitary-adrenal axis in cancer patients. J Interferon Res 13: 349-57, 1993.
18. Rovensky J, Vigas M, Lokaj J, Cuncik P, Lukac P, Takac A. Effect of growth hormone on the metabolic activity of phagocytes of peripheral blood in pituitary dwarfs and acromegaly. Endocrinol Exp 16: 129-34, 1982.
19. Rovensky J, Ferencikova J, Vigas M, Lukac P. Effect of growth hormone on the activity of some lysosomal enzymes in neutrophilic polymorphonuclear leukocytes of hypopituitary dwarfs. Int J Tissue React 7: 153-9, 1985.
20. Fu YK, Arkins S, Wang BS, Kelley KW. A novel role of growth hormone and insulin-like growth factor-I. Priming neutrophils for superoxide anion secretion. J Immun 146: 1602-8, 1991.
21. Spadoni GL, Spagnoli A, Cianfarani S, Del-Principe D, Menichelli A, Di-Giulio S, Boscherini B. Enhancement by growth hormone of phorbol diester-stimulaled respiratory burst in human polymorphonuclear leukocytes. Acta Endocrinol Copenh 124: 589-94, 1991.
22. Wiedermann CJ, Niedermuhlbichler M, Geissler D, Beimpold H, Braunsteiner H. Priming of normal human neutrophils by recombinant human growth hormone. Br J Haematol 78: 19-22, 1991.
23. Wiedermann CJ, Niedermuhlbichler M, Beimpold H, Braunsteiner H. In vitro activation of neutrophils of the aged by recombinant human growth hormone. J Infect Dis 164: 1017-20, 1991.
24. Warwick Davies J, Lowrie DB, Cole PJ. Growth hormone is a human macrophage activating factor. Priming of human monocytes for enhanced release of H2O2. J Immun 154: 1909-18, 1995.
25. Edwards CK, Ghiasuddin SM, Schepper JM, Yunger LM, Kelley KW. A newly defined property of somatotropin: priming of macrophages for production of Superoxide anion. Science 239: 769-71, 1988.
26. Wiedermann CJ, Reinisch N, Braunsteiner H. Stimulation of monocyte chemotaxis by human growth hormone and its deactivation by somatostatin. Blood 82: 954-60, 1993.
27. Wiedermann CJ, Reinisch N, Kahler C, Geisen F, Zilian U, Herold M, Braunsteiner H. In vivo activation of circulating monocytes by exogenous growth hormone in man. Brain Behav Immun 6: 387-93, 1992.
28. Edwards CK, Lorence RM, Dunham DM, Arkins S, Yunger LM, Greager JA, Walter RJ, Dantzer R, Kelley KW. Hypophysectomy inhibits the synthesis of tumor necrosis factor alpha by rat macrophages: partial restoration by exogenous growth hormone or interferon gamma. Endocrinology 128: 986-9, 1991.
29. Kappel M, Hansen MB, Diamant M, Pedersen BK. In vitro effects of human growth hormone on the proliferate responses and cytokine production of blood mononuclear cells. Horm Metab Res 26: 612-4, 1994.
30. Røkke O, Revhaug A, Østerud B, Giercksky KE. Increased plasma levels of endotoxin and corresponding changes in circulatory performance in a porcine sepsis model: the effect of antibiotic administration. In: Levin J. Buller HR, ten Cale JW, van Deventer SJH, Sturk A, eds. Bacterial endotoxins. Pathophysiological effects, clinical significance and pharmacological control. New York: Alan R. Liss, Inc., 247-62, 1988.
31. Bassoe CF, Laerum OD, Solberg CO, Haneberg B. Phagocytosis of bacteria by human leukocytes measured by flow cytometry. Proc Soc Exp Biol Med 174: 182-6, 1983.
32. Sjursen H, Bjerknes R, Halstensen A, Naess A, Sornes S, Solberg CO. Flow cytometric assay for the measurement of serum opsonins to Neisseria meningitidis serogroup B, serotype 15. J Immunol Meth 116: 235-43, 1989.
33. Wenisch C, Parschalk B, Hasenhundl M, Wiesinger E, Graninger W. Effect of cefodizime and ceftriaxone on phago-cytic function in patients with severe infections. Antimicrob Agents Chemother 39: 672-6, 1995.
34. Hansen JB, Halvorsen DS, Haldorsen BC, Olsen R, Sjursen H, Kierulf P. Retention of phagocytic functions in cryopreserved human monocytes. J Leukoc Biol 57: 235-41, 1995.
35. Bjerknes R, Bassoe CF. Phagocyte C3-mediated attachment and internalization: flow cytometric studies using a fluorescence quenching technique. Blut 49: 315-23, 1984.
36. Rothe G, Oser A, Valet G. Dihydrorhodamine 123: a new flow cytometric indicator for respiratory burst activity in neutrophil granulocytes. Naturwissenschaften 75: 354-5, 1988.
37. Espevik T, Nissen-Meyer J. A highly sensitive cell line, WEH1 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immun Meth 95: 99-105, 1986.
38. Zimmerman JJ, Ringer TV. Inflammatory host responses in sepsis. Crit Care Clin 8: 163-89, 1992.
39. Trautinger F, Hammerle AF, Poschl G, Micksche M. Respiratory burst capability of polymorphonuclear neutrophils and TNF-alpha serum levels in relationship to the development of septic syndrome in critically ill patients. J Leukoc Biol 49: 449-54, 1991.
40. Petty HR, Francis JW, Boxer LA. Deficiency in immune complex uptake by chronic granulomatous disease neutrophils. J Cell Sci 90; 425-32, 1988.
41. Solomkin JS, Bauman MP, Nelson RD, Simmons RL. Neutrophils dysfunction during the course of intra-abdominal infection. Ann Surg 194: 9-17, 1981.
42. Yuge O, Nomura M, Mukaida K, Yoshida A, Kawamoto M, Mono M. Depression factors of neutrophil bactericidal activity with nitroblue tetrazolium reduction test in surgical patients. In Vivo 2: 195-9, 1988.
43. Becker J, Grasso RJ. Suppression of yeast ingestion by dexamethasone in macrophage cultures: evidence for a steroid-induced phagocytosis inhibitory protein. Int J Immunopharmacol 10: 325-38, 1988.
44. Fu YK, Arkins S, Li YM, Dantzer R, Kelley KW. Reduction in Superoxide anion secretion and bactericidal activity of neutrophils from aged rats: reversal by the combination of gamma interferon and growth hormone. Infect Immun 62: 1-8, 1994.
45. Sakurai Y, Zhang XJ, Wolfe RR. Effect of tumor necrosis factor on substrate and amino acid kinetics in conscious dogs. Am J Physiol 266: E936-45, 1994.
46. Goodman MN. Tumor necrosis factor induces skeletal muscle protein breakdown in rats. Am J Physiol 260: E727-30, 1991.
47. Hesse DG, Tracey KJ, Fong Y, Manogue KR, Palladino MA, Jr., Cerami A, Shires GT, Lowry SF. Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet 166: 147-53, 1988.
48. Redl H, Schlag G, Adolf GR, Natmessnig B, Davies J. Tumor necrosis factor (TNF)-dependent shedding of the p55 TNF receptor in a baboon model of bacteremia. Infect Immun 63: 297-300, 1995.
49. Stack AM, Saladino RA, Thompson C, Sattler F, Weiner DL, Parsonnet J, Nariuchi H, Siber GR, Fleisher GR. Failure of prophylactic and therapeutic use of a murine anti-tumor necrosis factor monoclonal antibody in Escherichia coli sepsis in the rabbit. Crit Care Med 23: 1512-8, 1995.
50. Fisher CJ, Jr., Opal SM, Dhainaut JF, Stephens S, Zimmerman JL, Nightingale P, Harris SJ, Schein RM, Panacek EA, Vincent JL, et al. Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group. Crit Care Med 21: 318-27, 1993.
51. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Hariri RJ, Fahey TJ, Zentella A, Albert JD, et al. Shock and tissue injury induced by recombinant human cachectin. Science 234: 470-4, 1986.
52. Larrick JW, Graham D, Toy K, Lin LS, Senyk G, Fendly BM. Recombinant tumor necrosis factor causes activation of human granulocytes. Blood 69: 640-4, 1987.
53. Shalaby MR, Palladino MA, Jr., Hirabayashi SE, Eessalu TE, Lewis GD, Shepard HM, Aggarwal BB. Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha. J Leukoc Biol 41: 196-204, 1987.
54. Tsujimoto M, Yokota S, Vilcek J, Weissmann G. Tumor necrosis factor provokes Superoxide anion generation from neutrophils. Biochem Biophys Res Commun 137: 1094-100, 1986.
55. Porteu F, Nathan C. Shedding of tumor necrosis factor receptors by activated human neutrophils. J Exp Med 172: 599-607, 1990.
56. Lantz M, Bjornberg F, Olsson I, Richter J. Adherence of neutrophils induces release of soluble tumor necrosis factor receptor forms. J Immun 152: 1362-9, 1994.
57. Olsson I, Lantz M, Nilsson E, Peetre C, Thysell H, Grubb A, Adolf G. Isolation and characterization of a tumor necrosis factor binding protein from urine. Eur J Haematol 42: 270-5, 1989.